102 related articles for article (PubMed ID: 526922)
21. Evaluation of vincristine, CCNU and methyl-CCNU at high level doses in an experimental murine renal adenocarcinoma model.
Williams PD; Kantor P; Murphy GP
Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):529-36. PubMed ID: 7255884
[TBL] [Abstract][Full Text] [Related]
22. In vivo study of acute hematotoxicity of three nitrosoureas, chlorozotocin (chloro-2-ethyl)-ribofuranosyl-3-nitrosourea, and (chloro-2-ethyl)-1-ribopyranosyl-3-nitrosourea.
Mori KJ; Jasmin C; Hayat M; MacDonald JS; Mathé G
Cancer Res; 1980 Nov; 40(11):4282-6. PubMed ID: 6451285
[No Abstract] [Full Text] [Related]
23. Priming with low doses of methyl-CCNU reduce the toxicity of high doses of methyl-CCNU and melphalan, and increase the lifespan of mice implanted with Lewis lung carcinoma.
Zimber A; Perk K; Livnat I
Br J Cancer; 1988 Mar; 57(3):266-70. PubMed ID: 3355764
[TBL] [Abstract][Full Text] [Related]
24. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU.
Levin VA; Stearns J; Byrd A; Finn A; Weinkam RJ
J Pharmacol Exp Ther; 1979 Jan; 208(1):1-6. PubMed ID: 759602
[TBL] [Abstract][Full Text] [Related]
25. Comparative studies on the antitumor activity and the bone marrow toxicity of 1-(beta-D-glucopyranosyl)-3-(2-chloroethyl)-3-nitrosourea and 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose.
Aoshima M; Sakurai Y
Gan; 1977 Apr; 68(2):247-50. PubMed ID: 892299
[TBL] [Abstract][Full Text] [Related]
26. Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
Fujimoto S; Ogawa M; Sakurai Y
Cancer Res; 1982 Oct; 42(10):4079-85. PubMed ID: 6955008
[No Abstract] [Full Text] [Related]
27. Methyl-CCNU in malignant melanoma--a divided dose schedule of administration.
Wittes RE; Hong WK; Gatchell L; Krakoff IH; Golbey RB
Oncology; 1977; 34(1):45-6. PubMed ID: 865760
[TBL] [Abstract][Full Text] [Related]
28. Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma.
Creagan ET; Ahmann DL; Schutt AJ; Green SJ
Cancer Treat Rep; 1982 Jun; 66(6):1425-6. PubMed ID: 7083244
[TBL] [Abstract][Full Text] [Related]
29. Correlation of nitrosourea murine bone marrow toxicity with deoxyribonucleic acid alkylation and chromatin binding sites.
Green D; Tew KD; Hisamatsu T; Schein PS
Biochem Pharmacol; 1982 May; 31(9):1671-9. PubMed ID: 7104031
[TBL] [Abstract][Full Text] [Related]
30. The effect of high doses of methyl-CCNU on male and female fertility in SJL/J mice.
Yegana Y; Zimber A; Perk K
Anticancer Res; 1988; 8(3):397-401. PubMed ID: 3389744
[TBL] [Abstract][Full Text] [Related]
31. A biochemical and pharmacological study of therapeutic synergism with 5-fluorouracil plus cyclophosphamide in murine L1210 leukemia.
Fernandes DJ; Klubes P
Cancer Res; 1979 Apr; 39(4):1396-404. PubMed ID: 421224
[No Abstract] [Full Text] [Related]
32. Ultrastructral changes induced by 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea in L1210 lymphocytic leukemia cells in mice.
Fukuda K; Shindo H; Shimizu F; Arakawa M; Mizuhira V
Cancer Res; 1980 Jan; 40(1):133-8. PubMed ID: 7349893
[TBL] [Abstract][Full Text] [Related]
33. Baker's antifol in combination with 5-fluorouracil and methyl-CCNU in the treatment of metastatic colorectal cancer: a Southwest Oncology Group Study (Protocol 7764).
Shaw MT; Bonnet JD; Wilson H; Heilbrun LK
Cancer Treat Rep; 1980; 64(2-3):247-50. PubMed ID: 7407758
[TBL] [Abstract][Full Text] [Related]
34. [Combination chemotherapy of transplanted rat leukemia L 5222 with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and cyclophosphamide (CPA) as well as with methyl-CCNU and CPA (author's transl)].
Zeller WJ; Berger M
Arzneimittelforschung; 1981; 31(2):303-5. PubMed ID: 7194646
[TBL] [Abstract][Full Text] [Related]
35. Cain's quinolinium (NSC 176319): protection of murine L1210 leukemia cells and bone marrow progenitor cells against mechlorethamine cytotoxicity and its application to combination chemotherapy.
Naujokaitis SA
Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):97-104. PubMed ID: 7313308
[TBL] [Abstract][Full Text] [Related]
36. The in vivo cytotoxic activity of procarbazine and procarbazine metabolites against L1210 ascites leukemia cells in CDF1 mice and the effects of pretreatment with procarbazine, phenobarbital, diphenylhydantoin, and methylprednisolone upon in vivo procarbazine activity.
Shiba DA; Weinkam RJ
Cancer Chemother Pharmacol; 1983; 11(2):124-9. PubMed ID: 6627598
[TBL] [Abstract][Full Text] [Related]
37. Clinical results of autotransplantation after nitrosourea therapy.
Weiner RS; Richman CM; Yankee RA; Parker L
Exp Hematol; 1979; 7 Suppl 5():384-8. PubMed ID: 400701
[TBL] [Abstract][Full Text] [Related]
38. [Antitumor activity of a new nitrosourea, MCNU, on a cellular morphological basis evaluated by a new in vitro antitumor sensitivity assay].
Oguro M; Yanagawa T; Takenaga K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2550-6. PubMed ID: 6594974
[TBL] [Abstract][Full Text] [Related]
39. Effects of pretreatment with SKF-525A, N-Methyl-2-thioimidazole, sodium phenobarbital, or methyl cholanthrene on ethylenethiourea-induced teratogenicity in rats.
Khera KS; Iverson F
Teratology; 1981 Oct; 24(2):131-7. PubMed ID: 7336357
[TBL] [Abstract][Full Text] [Related]
40. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
Klubes P; Cerna I
Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
